Search results
The night basketball stopped: How NBA Twitter reacted to the league suspension four years ago
Hoops Hype via Yahoo Sports· 2 months agoFour years ago, the basketball world came to a screeching halt when bombshell news dropped: Rudy...
Here's Why Moderna May Dominate the Vaccine Market This Fall
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) shares climbed more than 2% yesterday after the company took a big step...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 1 week agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
FDA grapples with whether to modify COVID vaccine for fall
LA Times via Yahoo News· 2 years agoThe Food and Drug Administration will debate Tuesday whether it's time to update COVID vaccine...
Fact check: False claims about Pfizer vaccine stem from company's release of 80,000 pages of...
USA TODAY via Yahoo News· 2 years agoThe claim: 80,000 pages of Pfizer data show the vaccine has a 12% efficacy rate, harms fetuses As...
Fact check: New COVID-19 variants continue to be discovered
USA TODAY via Yahoo News· 1 year agoThe claim: COVID-19 variants are no longer being found An April 7 Instagram post (direct link,...
The Most Common Side Effects Of The New Bivalent COVID Booster
HuffPost Life via Yahoo News· 2 years agoHere's what you can expect when you get the bivalent COVID shot. (Photo: filadendron via Getty...
Will we be prepared for "Disease X?" Misinformation could leave us vulnerable to a future pandemic
Salon via Yahoo News· 4 months agoTEK IMAGE/SCIENCE PHOTO LIBRARY / Getty Images Pandemics have always been a major part of human...
This Could be Novavax's Big Opportunity
Motley Fool· 8 months agoEarly on in the pandemic, Moderna and Pfizer beat smaller rival Novavax (NASDAQ: NVAX) to market with their coronavirus vaccines by a year or more in...